Skip to content
OpenCapital
Get started

Lexeo Therapeutics, Inc. LXEO Q4 2025 Annual earnings

Reported March 30, 2026 · Before market open

EPS-$0.27Beat by $0.05
EPS estimate-$0.32

Next report

Aug 13, 2026 (In 2 weeks)
EPS estimate-$0.30

Versus estimates

Diluted EPS

Q1 2026-$0.25Beat by $0.04
Q4 2025-$0.27Beat by $0.05
Q3 2025-$0.33Beat by $0.15Q2 2025-$0.60Beat by $0.04Q1 2025-$0.99Miss by $0.19Q4 2024-$0.78Beat by $0.09

Ask the moment Lexeo Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Lexeo Therapeutics, Inc. report Q4 2025 earnings?
Lexeo Therapeutics, Inc. (LXEO) reported Q4 2025 earnings on March 30, 2026 before market open.
What were Lexeo Therapeutics, Inc.'s Q4 2025 revenue and EPS?
Lexeo Therapeutics, Inc. reported eps of $-0.27 for Q4 2025.
Did Lexeo Therapeutics, Inc. beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.32 by $0.05.
How did Lexeo Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 65.4% from $-0.78.
Where can I find Lexeo Therapeutics, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-131792) and the 10-K periodic report (0001193125-26-132085) directly on SEC EDGAR. The filing index links above go to sec.gov.